 |
 |
Return to Clinical Studies Main
Clinical Studies
5801: The Incidence of Thromboembolic Events in Patients with Antibodies to Heparin-PF4 after Cardiac Bypass
Status: Recruiting
Please Note: The Rare Diseases Clinical Research Network will make every effort to enroll all the patients we can, but we cannot make any guarantees that we will be able to enroll everyone in a particular study who wants to participate.
Summary:
The purpose of this study is to determine how often heart surgery patients who receive heparin develop an immune response (heparin-induced thrombocytopenia) that leads to clots forming in different parts of the body. These clots usually occur in the legs (deep venous thrombosis or DVT) or lungs (pulmonary embolism or PE) or cause heart attacks (myocardial infarction or MI) and strokes.
Target Enrollment:
Expected total enrollment is 800 patients, but the goal enrollment may be later modified.
Patients undergoing cardiac bypass surgery at any of the participating institutions will be screened. All ages are eligible for participation, as well as both genders.
How to Participate:
In order to participate in a study, you must personally contact the study coordinator of any of the participating institutions by phone or by e-mail. Please use the information below to inquire about participation.
- Duke University Medical Center, Durham NC
Mary Ann Gleim
Clinical Research Coordinator
Phone: 919-681-9564
E-mail: mary.gleim@duke.edu
- Mayo Clinic. Rochester, MN
LuAnne Koenig, RN
Clinical Research Coordinator
Phone: 507-284-4298
E-mail: koenig.luanne@mayo.edu
- University of Wisconsin, Madison, WI
Andrea Jones
Clinical Research Coordinator
Phone: 608-263-0517
E-mail: anj@medicine.wisc.edu
- Durham VA Medical Center, Durham, NC
Shahar Bar-Yosef, MD
Principal Investigator
Phone: 919-286-0411
E-mail: baryo001@mc.duke.edu
- University of North Carolina, Chapel Hill, NC
Robin Kellerman RN, BSN, MSS
Clinical Research Coordinator
Phone: 919-843-3942
E-mail: roberta_kellerman@med.unc.edu
You can learn more about this study by joining our contact registry!
|
Return to RDCRN Main Page